Macquarie University, 2 Technology Place(1.3 mi away)Contact
+1 other location
serum pregnancy test
This is a study to evaluate the safety and tolerability of the study drug HBM4003, and to
determine the maximum tolerated dose and/or recommended Phase 2 study dose of HBM4003.
Participants will receive 3 escalating doses of HBM4003, with the possibility of a fourth,
higher dose level following review by a Safety Committee. The study will also look at the
anti-tumor activity of HBM4003.
Clinical Study Identifier
Harbour BioMed US Ltd.
Last Modified on
20 January 2020
How clear was the trial content above?
Adding a note
Select a piece of text and start making personal notes.
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.